Company Fisher & Paykel Healthcare Corporation Limited Börse Stuttgart

Equities

FPLB

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Market Closed - Börse Stuttgart 02:18:04 2024-05-29 EDT 5-day change 1st Jan Change
15.9 EUR +3.92% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -1.29% +17.69%

Business Summary

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.

Sales per Business

NZD in Million2023Weight2024Weight Delta
Hospital
62.4 %
1,024 64.7 % 1,088 62.4 % +6.29%
Home Care
37.4 %
554 35.0 % 652 37.4 % +17.79%
Distributed and Other Products
0.1 %
4 0.2 % 3 0.1 % -31.58%

Sales per region

NZD in Million2023Weight2024Weight Delta
North America
46.3 %
684 43.2 % 806 46.3 % +17.89%
Europe
27.4 %
428 27.0 % 477 27.4 % +11.62%
Asia Pacific
21.2 %
399 25.2 % 369 21.2 % -7.54%
Other
5.2 %
71 4.5 % 91 5.2 % +28.01%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 84-12-31
Director of Finance/CFO - 19-02-28
Chief Tech/Sci/R&D Officer - 14-07-31
Chief Tech/Sci/R&D Officer - 06-12-31
Chief Tech/Sci/R&D Officer - 05-12-31
Director/Board Member 66 90-04-30
Public Communications Contact - 08-12-31
General Counsel - 23-05-08
Corporate Officer/Principal - 21-12-31
Human Resources Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 90-04-30
Chairman - 15-09-30
Chief Executive Officer 63 84-12-31
Director/Board Member 65 18-11-11
Director/Board Member 59 21-09-30
Director/Board Member - 22-05-31
Director/Board Member 59 23-09-30
Director/Board Member - 17-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 580,581,693 529,024,257 ( 91.12 %) 0 91.12 %

Shareholders

NameEquities%Valuation
36,059,206 6.175 % 607 M €
Hyperion Asset Management Ltd.
6.071 %
35,452,466 6.071 % 597 M €
First Sentier Investors (Australia) IM Ltd.
3.270 %
19,095,594 3.270 % 322 M €
Guardians of New Zealand Superannuation
2.242 %
13,090,409 2.242 % 221 M €
First Sentier Investors (Hong Kong) Ltd.
1.752 %
10,232,002 1.752 % 172 M €
Accident Compensation Corp.
1.566 %
9,144,701 1.566 % 154 M €
First Sentier Investors (Singapore)
1.309 %
7,643,874 1.309 % 129 M €
Australian Ethical Investments Ltd. (Investment Management)
1.055 %
6,159,764 1.055 % 104 M €
Smartshares Ltd.
0.9959 %
5,815,953 0.9959 % 98 M €
First Sentier Investors RQI Pty Ltd.
0.7184 %
4,195,380 0.7184 % 71 M €

Company contact information

Fisher & Paykel Healthcare Corp. Ltd.

15 Maurice Paykel Place East Tamaki

2013, Auckland

+

http://www.fphcare.com
address Fisher & Paykel Healthcare Corporation Limited(FPLB)
  1. Stock Market
  2. Equities
  3. FPH Stock
  4. FPLB Stock
  5. Company Fisher & Paykel Healthcare Corporation Limited